Chief Executive Officer at Tzar Labs
Tzar Labs is a molecular diagnostic company that specializes in the detection and prognosis of cancer at its earliest stage. Ashish Tripathi is the founder and CEO of Tzar Labs and Director of Epigeneres Biotech. The company has made a series of major breakthroughs in molecular diagnostics and he is spearheading the global launch. Prior to this, Ashish was the National TMT Head of Edelwiess IB and has had 20+ years of investment banking /corporate finance, M&A and corporate strategy experience across Australia, Europe, North America, Asia and Middle East.
Session
Medicine’s next frontier: Detect, decode, decipher
Global Bio India 2023 Auditorium 1 (Level 2), Bharat Mandapam, Pragati Maidan, New Delhi
Medicine is taking giant leaps into uncharted territory. The field of molecular diagnostics is galloping ahead and involves the taking of DNA or RNA, the unique genetic code found in our cells, and examining and analysing the data from specific sequences that can flag the potential occurrence of a disease. Scientists are focusing deeply on understanding various diseases through these new and ingenious diagnostic methods. For instance, in the fight against cancer, early detection is the Holy Grail and the most accepted early detection test for cancer is the HrC Test, a quick, minimally invasive method to evaluate expression levels of rare stem cell markers. In this session, experts in diagnostics focus on the future of the ingenuity that is transforming molecular pathology.
